McHardy; Stanton F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McHardy; Stanton F..The latest application filed is for "compositions and methods for treating schistosoma infections".

Company Profile

2.11.21

McHardy; Stanton F. - Waring TX
McHardy; Stanton F. - San Antonio TX
McHardy; Stanton F. - Conventry RI
McHardy; Stanton F. - Helotes TX
McHardy; Stanton F. - Coventry RI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Treating Schistosoma Infections App 20220227709 - McHardy; Stanton F. ; et al.	2022-07-21
Methods And Compositions For The Treatment Of Shiga Toxicosis App 20220202747 - Mukhopadhyay; Somshuvra ; et al.	2022-06-30
Methods and compositions for the treatment of Shiga Toxicosis Grant 11,304,916 - Mukhopadhyay , et al. April 19, 2	2022-04-19
Inhibition of OLIG2 activity Grant 11,242,323 - Beaton , et al. February 8, 2	2022-02-08
Inhibition Of Olig2 Activity App 20210347739 - BEATON; Graham ; et al.	2021-11-11
Inhibition Of Olig2 Activity App 20210253535 - BEATON; Graham ; et al.	2021-08-19
Inhibition Of Olig2 Activity App 20210114991 - BEATON; Graham ; et al.	2021-04-22
Inhibition Of Olig2 Activity App 20200407329 - BEATON; Graham ; et al.	2020-12-31
Methods And Compositions For The Treatment Of Shiga Toxicosis App 20200375923 - Mukhopadhyay; Somshuvra ; et al.	2020-12-03
Inhibition Of Olig2 Activity App 20190389812 - BEATON; Graham ; et al.	2019-12-26
Inhibition Of Olig2 Activity App 20180244631 - BEATON; Graham ; et al.	2018-08-30
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Grant 9,169,220 - McHardy , et al. October 27, 2	2015-10-27
Oximes For Treatment Of Peripheral And Central Nervous System Exposure to Acetyl Cholinesterase Inhibitors App 20150005328 - MCHARDY; Stanton F. ; et al.	2015-01-01
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Grant 8,772,345 - McHardy , et al. July 8, 2	2014-07-08
Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors App 20140066421 - McHardy; Stanton F. ; et al.	2014-03-06
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors Grant 8,653,108 - McHardy , et al. February 18, 2	2014-02-18
Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors App 20130035351 - MCHARDY; Stanton F. ; et al.	2013-02-07
Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors Grant 8,124,639 - McHardy , et al. February 28, 2	2012-02-28
Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors App 20100324020 - McHardy; Stanton F. ; et al.	2010-12-23
2-azabicyclo[3.3.1]nonane derivatives Grant RE40,838 - Coe , et al. July 7, 2	2009-07-07
3-Azabicyclo[3.1.0]hexane derivatives App 20070054950 - McHardy; Stanton F. ; et al.	2007-03-08
Bicyclic [3.1.0.] heteroaryl amides as type 1 glycine transport inhibitors App 20060229455 - McHardy; Stanton F. ; et al.	2006-10-12
3-azabicyclo[3.1.0]hexane derivatives Grant 7,049,335 - McHardy , et al. May 23, 2	2006-05-23
1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands Grant 6,960,609 - McHardy , et al. November 1, 2	2005-11-01
3-Azabicyclo[3.1.0]hexane derivatives App 20050171178 - McHardy, Stanton F. ; et al.	2005-08-04
3-azabicyclo[3.1.0]hexane derivatives App 20030087898 - McHardy, Stanton F. ; et al.	2003-05-08
1-Diphenylmethyl-pyrazole derivatives as opioid receptor ligands App 20030069241 - Mchardy, Stanton F. ; et al.	2003-04-10
Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies App 20020077323 - McLean, Stafford ; et al.	2002-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.